Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JKUU | ISIN: NO0010205966 | Ticker-Symbol: N1A
Frankfurt
21.11.24
09:06 Uhr
2,280 Euro
-0,040
-1,72 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NAVAMEDIC ASA Chart 1 Jahr
5-Tage-Chart
NAVAMEDIC ASA 5-Tage-Chart

Aktuelle News zur NAVAMEDIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiMajor shareholder disclosure in Navamedic ASA1
FrNavamedic ASA: Amendments to loan agreements with Observe Medical ASA190OSLO, Norway, Nov. 15, 2024 /PRNewswire/ -- Navamedic has two loans to Observe Medical ASA, Loan 1 from 27 September 2019, where the current balance, including principal and accrued interest...
► Artikel lesen
FrObserve Medical ASA: Amendments to loan agreements with Navamedic ASA3
NAVAMEDIC Aktie jetzt für 0€ handeln
06.11.Navamedic ASA: Mandatory notice of trade-
06.11.Navamedic ASA: Navamedic launches Eroxon[®] in Finland1
31.10.NAVAMEDIC ASA: Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business1
28.10.Navamedic ASA: Invitation to 2024 3rd quarter presentation1
07.10.Navamedic ASA: Navamedic wins joint Nordic antibiotics tender-
19.09.Navamedic ASA - Registration of share capital increase1
12.09.Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson's Disease225STOCKHOLM, Sept. 12, 2024 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has partnered with...
► Artikel lesen
09.09.Navamedic ASA - Mandatory notification of trade by primary insider-
09.09.NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS1
21.08.Navamedic ASA - Mandatory notice of trade1
16.08.Navamedic ASA: Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement262OSLO, Norway, Aug. 16, 2024 /PRNewswire/ -- In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies...
► Artikel lesen
12.08.Navamedic ASA: Invitation to 2024 2nd quarter presentation1
24.06.Navamedic ASA: Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe274OSLO, Norway, June 24, 2024 /PRNewswire/ -- Navamedic ASA and Orion Corporation ("Orion") have today signed a license and supply agreement for Flexilev®, including the OraFID® dispenser,...
► Artikel lesen
04.06.Navamedic ASA: Minutes of Annual General Meeting456OSLO, Norway, June 4, 2024 /PRNewswire/ -- The Annual General Meeting of Navamedic ASA was held today at 09:00 CEST. All items on the agenda were resolved in accordance with the board of...
► Artikel lesen
16.05.Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals335OSLO, Norway, May 16, 2024 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation...
► Artikel lesen
06.05.Navamedic ASA: Broad launch for Eroxon® in Sweden today363OSLO, Norway, May 6, 2024 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies has launched Eroxon®...
► Artikel lesen
23.04.Navamedic ASA: Invitation to 2024 1st quarter presentation190OSLO, Norway, April 23, 2024 /PRNewswire/ -- Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The presentation will be held at Haakon...
► Artikel lesen
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1